Loading...
Market
Will Martin Shkreli pay the $64.6M penalty in full by end of 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Public financial records or statements from the court or Shkreli's legal team
Story
Supreme Court Rejects 'Pharma Bro' Shkreli's Appeal Over $64.6M Penalty for 4,000% Drug Price Hike
Oct 7, 2024, 03:21 PM
The U.S. Supreme Court declined to hear former pharmaceutical executive Martin Shkreli's appeal against a $64.6 million financial penalty imposed by a judge. Shkreli, infamously known as the 'Pharma Bro', had raised the price of a life-saving drug by more than 4,000%, increasing the cost by over $700 per pill. He was penalized for blocking competition to the drug. The decision leaves in place the antitrust judgment against him.
View original story
Similar markets
Yes • 50%
No • 50%
Fines • 25%
Imprisonment • 25%
Both fines and imprisonment • 25%
No legal consequences • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
All copies surrendered • 25%
Partial copies surrendered • 25%
No copies surrendered • 25%
Unable to determine • 25%
PleasrDAO gains full ownership • 25%
Shkreli retains partial rights • 25%
Joint ownership agreement • 25%
Other outcome • 25%